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Summary
1 Abbreviation used in this paper. BM, bone marrow.
Transplantation of bone marrow cells of Ipr/lpr mice into irradiated normal mice fails to develop
massive lymphadenopathy or autoimmunity but causes severe graft-vs.-host-like syndrome. To
elucidate an abnormality of Ipr/lpr bone marrow-derived T cells, we transplanted bone marrow
cells of Mlsb lpr/1pr mice into H-2-compatible Mls' non-lpr mice. Although lpr/lpr T cell
precursors repopulated the host thymus as well as +/+ cells, a proportion of CD4+CD8+ cells
decreased, and that of both CD4 - and CD8- single-positive cells increased compared with those
of +/+ recipients. Notably, in MRL/Ipr- AKR and C3H/Ipr-" AKR chimeras, CD4 single-
positive thymocytes contained an increased number of Va6+ cells in spite of potentially deleting
alleles of Mls', whereas V06+ mature T cells were deleted in the MRL/+ - AKR and C3H/+
AKR chimeras. There was no difference between MRL/+ -" AKR and MRL/Ipr - AKR
chimeras in their proportion of Va3+ cells because both host and donor strain lack the deleting
alleles. Interleukin 2 receptor expression of mature T cells, in the thymus and lymph node, was
obviously higher in the MRL/Ipr - AKR chimeras, in particular in the "forbidden" V06+
subset. Moreover, 1pr donor-derived peripheral T cellsshowed vigorous anti-CD3 response. These
results indicate that Ipr-derived T cells escape not only tolerance-related clonal deletion but also
some induction of unresponsiveness in the non-lpr thymus.
M
ice homozygous for the 1pr gene spontaneously develop
a massive T cell proliferation and an autoimmune syn-
drome with age (1, 2). The bulk of evidence favors the view
that an essential abnormality in IF mice presents in T cell
lineage. The major population of cells accumulating in the
lymphoid tissue is a unique subset of Thy-1+, L3T4 - , Lyt-
2 - , B220+, and Pgp-1+ (3-5). They seem to belong to a
T cell lineage in consideration for expression of TCR-cx/g
(6), albeit at low density, lack of Ig gene rearrangements (4),
and generation in the thymus (7). Neonatal thymectomy
reduces lymphadenopathy and autoimmune syndrome (8, 9).
Thymus grafting into neonatally thymectomized lpr mice
causes recurrence of lymphoproliferation, irrespective of thymic
genotype (10). Transplantation of normal bone marrow
(BM)l into 1pr mice prevents the development of the disease
(11, 12). Non-lpr BM cellstransferred into lpr mice with Thy-
1-congeneic 1pr BM do not contribute to form accumulating
B220+ CD4-CD8- T cells (13). These phenomena suggest
an importance of the existence of the thymus for develop-
ment of the disease and an intrinsic abnormality in 1pr stem
cells.
Transplantation of 1pr BM cells into irradiated normal mice
fails to develop massive lymphadenopathy or autoimmunity
but causes severe wasting syndrome (11, 14, 15), i.e., loss of
body weight, progressive fibrosis, and cellular depletion of
lymphoid tissue (14) . Although the syndrome resembles sub-
acute GVHD, transplantation of T cell-depleted BM cells
or fetal livercells does not prevent the GVHD-like syndrome
(14). The cellular basis of the lpr-associated GVHD remains
unknown. Supposing that this lpr-associated wasting syndrome
is also mediated by T cell lineage, the effector T cells must
be generated in the host thymus. As for radiation BM chimeras,
injected donor-derived T cell precursors colonize the host
thymus and proliferate under the influence of the thymic en-
vironment, resulting in undergoing thymic selection, which
includes clonal deletion (16, 17).
To investigate intrathymic selection of 1pr BM-derived T
cells, we transplanted BM cells of Mlsb Ipr/lpr mice into
H-2-compatible Mls, non-lpr mice. Here, we show that lpr-
derived T cells escape clonal deletion in the non-Ipr thymus
and that,, from data of IL2R expression and proliferative re-
sponse, they are highly activated in vivo. The implications
of these findings for a mechanism of self-tolerance and a rela-
tionship to subsequent manifestation of wasting syndrome
in the lpr-non-lpr chimeras are discussed.
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Mice. Female AKR/JSea(AKR,H-21,Thy-1.1,Mls'/Mls-1121)
mice and MRL/Mp-lpr/1pr(MRL/Ipr,H-2k,Thy-1.2,Mls1/Mls-1121)
mice were obtained from Seiwa Experimental Animals (Nakatsu,
Japan). Female C3H/He(C3H/+,H-2k,Thy-1.2,Mls°/Mls-1121) and
female C57BL/6(B6,H-21Thy-1.2,M1s1/Mls-1121) mice were from
theJapan SLCInc. (Hamamatsu, Shizuoka,Japan). Breeding pairs
of MRL/Mp-+/+(MRL/+,H-2kThy-1 .2,Mis1/Mls-11 21) and C3H/
HeJ-lpr/lpr(C3H/1pr,H-2kThy-1.2,Mls°/Mls-112') mice were ob-
tained from TheJackson Laboratory (Bar Harbor, ME) and main-
tained under a specific pathogen-free condition at our institute.
Chimeras.
￿
8-wk-old AKR mice, or C3H mice in .some experi-
ments, were lethally irradiated (950 rad, 60Co source), and 6 h
later, these mice were reconstituted with 5 x 106 bone marrow
cells from 8-wk-old MRL/Ipr, C3H/lpr, and their +/+ controls.
The BM cells were treated with anti-CD4(GK1.5) and anti-CD8
mAbs (anti-mouse Lyt-2.1 or Lyt-2.2; Meiji Institute of Health
Science, Tokyo) and complement, then were washed three times
with Hanks' balanced solution before reconstitution.
Preparation of T Cells.
￿
Thymocytes were purified according to
the panning method as previously described (18). Cell suspensions
were poured onto antiThy-1.1 mAb (Meiji Institute of Health
Science)-coated dishes. After incubation for70 minat 4°C, nonad-
herent cells were removed and the bound cells were recovered by
flushing. After two cycles of selection, >97% of therecoveredcells
were Thy-1.1' or Thy-1.2' cells. In some experiments, Thy-1.2'
cells were further separated into CD8- andCD8' cells using anti-
CD8 mAb-coated dishes. LN cells were aseptically obtained from
axillary, inguinal, and mesenteric nodes and were suspended in
RPMI 1640 supplemented with 10% heat-inactivated FCS. The
cells were treated with antiThy-1.1 mAb plus complement to re-
move radioresistant host-derived T cells.
Flow Microfuorometry.
￿
FITC-conjugated antiThy-1.2, PE-con-
jugated anti-CD4 mAbandFITC-conjugated anti-CD8 mAbwere
purchasedfrom Becton Dickinson & Co. (Oxnard, CA). The hy-
bridoma secretinganti-CD3 mAb (clone 145-2C11)was grown in
vitro, and the supernatant was precipitated by ammonium sulfate
andwas purified through a protein A column. Purified anti-CD3
mAbwas conjugated with FITC in ourlaboratory. Undilutedcul-
ture supernatant of rat hybridoma, 44-22-1, was used as a mAb
that recognizes all TCRs usingV06 gene segments (19) followed
by FITC-conjugated goat anti-rat IgG(Tago Inc., Burlingame, CA).
mAb KJ16-133, whichrecognizes TCRs usingproducts of theV/08
gene family (V08.1/8.2; 20) was also used. Culture supernatant
of hamster hybridoma, KJ25, was used as a mAb that recognizes
all TCRs using V/03 gene segments (21) followed by FITC-con-
jugated goat anti-hamster IgG (Tago Inc.). Anti-IL-21k mAbwas
purified from culture supernatant of 7134 (22) by separation with
HPLC and was biotinylated in our laboratory. To stain CD4 vs.
TCR VA 106 cells were incubated with antiV/3 supernatant first,
FITC-conjugated anti-rat (mouse) IgG second, andthen followed
by PE-conjugated anti-CD4 mAb for 40 min for each staining at
4°C. For staining IL2R vs. TCR VA first and second FITC
stianings were followed by biotinylated anti-IL2R-ce (7134) mAb
and PE-streptavidin. In V/36 and Vf38 staining, samples were in-
cubated with twice-diluted rat serum afterFITC-conjugated anti-
rat IgG staining to block unoccupied binding sites. All samples
were treatedwith ammonium chloride to remove erythrocytes and
analyzed on FACScan or FACS440 flow cytometer (Becton Dick-
inson & Co.). Dead cells and debris were excluded from analysis
by selective gating based on anterior and right angle scatter. In
most experiments, 5 x 104 flow cytometerevents were analyzed,
using Consort 30 software. All data were collected and displayed
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on a log scale of increasing green and red fluorescence intensity.
Data were presented as two-dimensional contour maps or histo-
grams. To obtain percentages ofthe thymocytesubpopulations, total
counts were integrated in selected areasof thecontourplots. IL2R
expression on T cell subpopulations was determined by software
gating using one staining parameter (CD3, V06, V03, Thy-1.2).
In Vitro Proliferation Assay.
￿
Cellswere cultured in 96-well, flat-
bottomed microtiter plates (Coster, Cambridge, MA)with avolume
of 200 1l RPMI 1640 supplemented with 10% nu serum, 10
mM Hepes, 2 MM L-glutamine, 5 x 10 -5 M 2-ME, and 50 1~g
Kanamycine. Anti-CD3 mAb wasaddedat various concentrations.
106 cells were distributed into each well. After 48 h ofincubation
at 37°C in 5% CO2, cultures were pulsed with [3H]thymidine for
an additional 18 h. The cells from individual wells were then col-
lected on filter papers with an automatic harvester and assayed for
radioactivity in a liquid scintillation counter.
Results
Regeneration andReplacement of Thymocytes in WholeBody-
irradiated BM Chimeras. Recipient AKR mice (H-2k,Thy-
1.1,Mls') were lethally irradiated and reconstituted with
marrow cells from lpr mice of MRL (H-2k,Thy-1.2,MIsb)
or C3H (H-2k,Thy-1.2,Mlsc) strains. Thymocytes from the
recipients were serially harvested, counted, and stained with
FITC-conjugated anti Thy-1.2. As shown in Fig. 1, the total
cell numbers in the thymus decreased to the lowest value on
day 7 after reconstitution and then increased exponentially.
Host Thy-1.1+ thymorytes were almost completely replaced
by Thy-1.2+ cells by day 21 after BM transplantation. T cell
precursors derived from lprmice repopulated thehost thymus
as well as normal mice-derived cellsdid. However, in recipients
of lpr BM cells, total cell number of thymorytes gradually
declined aftercomplete replacement of thethymus, while that
in recipients of +/+ BM cellsrecoveredto theoriginal volume
before irradiation.
Subsequent analysis on CD4 and CD8 expression of the
thymocytes revealed an unusual pattern of differentiation of
1pr-derived cells. Thy-1.2-positive (donor-derived) cells were
purified from whole thymorytes by the panning method. Fig.
2 demonstrates sequential appearance of expression of the
donor-derived thymorytes at the earlystage of BM transplan-
tation. On days 14 and 21, a relatively early stage, there is
no difference between MRL/+ - AKR and MRL/Ipr
AKR chimeras. On and afterday 28, in MRL/Ipr - AKR,
a proportion of the double-positive (CD4+CD8') subset
decreased, and that of the single-positive (both CD4+CD8-
and CD4-CD8+) cells became higher. Taking the decrease
of total cell number into consideration, that change in the
ratio of each subset may be mainly attributed to a decrease
of the number of double-positive cells, which seems to be
a precursor of the mature T cell and the critical stage of in-
trathymic negative selection process (23, 24). However, lpr
BM-derived T cell precursors colonized, proliferated, and
differentiated in the host thymus and consequently gave rise
to "mature-type" single-positive cells as well as control BM-
derivedT precursors did. Most of single-positive thymorytes
that appeared in theMRL/lpr- AKRandMRL/+ -AKR
chimeras expresseda high intensityof CD3 afterday28 (data
not shown).H
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Figure 2.
￿
Expression of CD4 and CD8 by donor-derived thymocytes
on day 14 (a and b), day 21 (c andd), andday 35 (e andf). Samples were
obtained from MRL/+ -AKRchimeras (a, c, ande) andMRL/Ipr -+
AKRchimeras (b, d, andf). Host-derived radioresistant thymocytes were
removed by the panning method, as described in Materials andMethods.
All the applied samples were >98% Thy-1.2+ .
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Figure 1.
￿
Regeneration of thymo-
cytes in the thymus ofthe irradiated host
mice. (0) Total cell count of the
thymus; (/)cell count ofdonor-derived
(Thy-1.2+) thymocytes: (total cell
count) x (percentage of Th)-1.2+
cells/100). Each point represents the
mean value of three to five samples.
TCRExpression ofCD4 Singlepositive Thymocytes.
￿
In the
thymus of Mlsa mice, Va6+ cells are selectively deleted in
mature (CD4+CD8-CD3+ or CD4 - CD8+CD3+) subsets
(19, 25). Further, V06+ cells are also deleted in Mlsb -" Mlsa
radiation chimeras (26), even at the early stage (27) of BM
transplantation. The analysis of clonal deletion of V06+ and
V08.1+ cells in Mlsa mice indicated that class II-expressing
cells might be involved in the deletion process (19, 26, 28),
thereby, we investigated an expression of several TCR V(3
on CD4 single-positive thymocytes in order to estimate clonal
deletion in the thymus of (Mlsb,lpr) - (Mlsa,non-lpr) chi-
meras. Results from analysis on CD8-depleted thymocytes
on days 28-42 were summarized in Table 1, and typical data
were presented in Fig. 3. Notably, CD4 single-positivethymo-
cytes from lpr/lpr --" AKR chimeras contained an appreciate
number of V06+ cells (Fig. 3, e and k). On the other hand,
in the +/+ recipients, CD4 single-positive thymocytes did
not contain V,66+ cells because of probable clonal deletion
in the Mlsa host thymus. In the case of MRL --> AKR
chimeras, there was no difference between lprllpr and +/+
recipients in proportion of V03+ cells (Fig. 3, c and f),
which are deleted in neither host nor donor strain. A fre-
quency of KJ16+ cell was higher in C3H/lpr -" AKR chi-
meras (1) compared with that in C3H/+ - AKR chimeras
(i) probably due to the frequency of V08.1+ cells.
Two possibilities couldbe brought forward to explain this
finding. (a) T cells derived from lpr BM are unusual in being
not subjected to clonal deletion; and (b) APC from lpr BM
appeared in the thymus to have a defect in tolerance-related
antigen presenting ability. To investigate these possibilities,
we constructed mixed chimeras that were transplanted with
mixture ofBM cells from MRL/Ipr and AKR. The (MRL/Ipr+ AKR) - AKR chimeras showed complete deletion of
lpr-derived (Thy-1.2+) V06+ mature thymorytes (Table 1),
suggesting that normal We APC have an ability to induce
clonal deletion to lpr-derived T cells, and that lpr-BM de-
rived T cells can be subjected to clonal deletion. However,
weight loss and lymphoid atrophy were also observed in
(MRL/Ipr + AKR) - AKR chimeras, indicating that mere
defect in clonal deletion is not sufficient to explain pr-associated
GVHD.
Next, to determine whether failure to delete V/36 is unique
or representative of a generalized failure to delete self-reactive
T cells, the MRL --> C3H(Mls') chimeric combination was
investigated. As shown in Table 1, no significant difference
was seen between MRL/Ipr - C3H and MRL/+ - OH
chimeras in V03 expression. Relatively fewer VO3+ cells
made it difficult to analyze. It is not likely that Va6+ T cells
preferentially contribute to 1pr GVHD because expression of
V06 was not significantly elevated in 1pr - OH compared
with +/+ - C3H. Wasting appearance and fibrosis of the
spleen were not so severe in MRL/lpr - OH as in MRL/Ipr
AKR chimeras.
Spontaneous Activation oflpr-derived T Cells.
￿
If "forbidden"
T cells, which are able to recognize and respond to self-antigen,
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The values represent V(3+ percentage in CD4+CD8 - cells. Five to six mice were examined and the mean value (± SEM) is given.
Lethally irradiated AKR mice were reconstituted with 4 x 106 BM cells from MRL and the same number of cells from AKR. Percent Thy-1.2
of recovered thymocytes was 27.8 ± 4.3 (4 wk) and 22.0 ± 11 .3 (6 wk). Cells were then depleted of Thy-1.1* cells by the panning method and
purified to >98% Thy-1 .2* .
t Percent Thy-1.2 of initially recovered thymocytes was 53 .1 ± 10.0 (4 wk) and 24.8 ± 11.1 (6 wk).
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exist in the thymus of 1pr recipients, they should be receiving
an intense, continuous stimulation. To confirm a degree of
activation of T cells in the MRL/lpr --> AKR chimeras, we
assessed an expression of IL2R on each particularVO subset
using antiTac mAb (22, 29). Assays were carried out on day
35 after BM transplantation . Representative data are shown
in Fig. 4. Va6+CD4+CD8 - thymocytes were deleted in
MRL/+ -" AKR (a) and appeared in MRL/Ipr -> AKR
(b), C57BL/6 (IE- ) -> AKR (c), and MRL/Ipr - OH (d)
chimeras. Particularly in the "forbidden" V06+ subset, which
was seen in 1pr -" AKR chimeras (e), IL2R expression was
nearly three times higher than 1pr - OH chimeras(g). Al-
though B6(1-E - ) --> AKR chimeras also allow an appear-
ance of V06+ cells, IL-2R expression of CD4+Va6+ thy-
mocytes in this combination is not increased (Fig. 4f), as
reported on SJL(H-25) - B6 x CBA/J chimeras (30), and
is virtually equivalent to that of untreated young MRL/Ipr
mice and MRL/+ mice (data not shown). The V03+ subset
seen in 1pr - AKR chimeras also contained more IL-2R+
cells (Fig. 4 m) than MRL/+ - AKR chimeras (1), but less
than the V06+ subset of the identical individuals. Incidence
of IL-2R+ cells in CD3h'gh thymorytes (p) and peripheral
donor-derived (Thy-1.2+) T cells of MRL/Ipr - AKR
Table 1, lpr Mice-derived V,B6+CD4 + CD8-
4 wk
Thymocytes Escape Clonal
Percent V06' at:
5 wk
Deletion
6 wk
in Irradiated Mis-1°
4 wk
Hosts
Percent VQ3+ at:
5 wk 6 wk
MRL/+ - AKR 0.78 0.76 0.73 ND 6.96 6.62
(0.22) (0.07) (0.20) (0.71) (0.55)
MRL/Ipr- AKR 3.70 3.02 2.81 ND 6.67 7.45
(0.70) (0.11) (0.99) (0.13) (0.86)
C3H/ + -"AKR 1.20 1.16 0.73 ND ND ND
(0.24) (0.38) (0.31)
C3H/lpr-AKR 4.66 2.73 1.61 ND ND ND
(0.83) (0.81) (0.15)
MRL/+,AKR-AKR" 1.96 ND 1.43 ND ND 6.48
(0.08) (0.71) (0.51)
MRL/1pr,AKR-AKRt 1 .58 ND 1 .65 ND ND 5 .79
(0.26) (0.99) (0.96)
MRL/+-C3H 8.84 8.62 ND 1.36 1 .67 ND
(0.34) (0.48) (0.42) (0.60)
MRL/lpr-C3H 9.08 8.00 ND 2.08 1 .79 ND
(0.25) (0.33) (0.64) (0.96)Q
U
naive C3H/+ 9
8.6%
. _....,
CD8-depleted thymocytes
V,6 6
Kit b
0.5%
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chimeras (t) was higher than those of MRL/+ - AKR
chimeras (o and s) . In MRL/lpr -> C3H, IL2R expression
was slightly increased in CD3high thymocytes and was twice
increased in Thy-1.2+ LN cells compared with its control
(not shown), however, less apparent than in the MRL ->
AKR combinations.
In lpr --> non-lpr chimeras, cell numbers in lymphoid tissue
gradually decreased to <1% of that in control chimeras by
day 70 after BM transplantation (14; and our data). To esti-
mate a proliferative capacity of lpr-derived surviving T cells,
we investigated in vitro response to anti-CD3 mAb on day
35, that is, before complete lymphoid atrophy. LN cells from
chimeras were treated with antiThy-1.1 mAb plus comple-
f
6.9%
V63
Figure 3.
￿
Expression of TCR VB6 (a, b, d, e,
g, h, j, and k), V03 (c and.), and V08 (i and 1).
Samples were obtained from 8-wk-old untreated
mice (a, d, g, ands), MRL/+ -" AKR (b and c),
MRL/lpr - AKR (e and j), C3H/+ - AKR
(h and i), and C3H/lpr - AKR chimeras (k and
CD8' cells were depleted by the panning
method using anti-Lyt-2.1-coated dishes. Nonad-
herent cells were stained and analyzed by two-color
flow cytometry. Data represent one ofthe five mice
tested. The otherfour showed similar staining pat-
terns in each panel. All the applied samples were
>99% Thy-1.2+ and contained <2% CD8' cells.
The value in each figure represents F11-positive
percentage in F12(CD4)-positive cells (quadrant
1/quadrant 1 + quadrant 2).
ment to remove radioresistant host-derived T cells. As shown
in Table 2, donor-derived T cells from MRL/lpr -" AKR
chimeras virtually exhibited spontaneous proliferation without
stimulation and an unusual high but dose-dependent response
to anti-CD3 mAb; it is compatible with increased IL-2R ex-
pression of peripheral T cells. Taken together, these results
suggest in vivo activation of lpr-derived T cells that have
differentiated in the host thymus.
Discussion
Generally, in radiation BM chimeras, donor-derived T cell
precursors that colonize the host thymus proliferate exponen-Thy1 .2' S
4 .5
t
35 .5 A
I L 2 R ( 7 D 4 )
C
6.8
C57BL/6 - AKR
2 .9
u
tially in the thymic environment and then undergo a thymic
education including clonal deletion of self-reactive cells. Donor
BM-derived mature T cells, emigrating from the thymus,
come to get unresponsiveness to the host antigens even in
fully allogeneic combinations (16) . However, results from lpr
--> non-1pr chimeras do not seem to be consistent with this
accepted view on BM chimeras. We have detected a "forbidden"
V06+ clone in the thymus of AKR (Mls') reconstituted
with BM of H-2-compatible Mlsb lpr/lpr mice. Furthermore,
on the basis of the results of increased IL2R expression and
anti-CD3 mAb response, lpr-derived mature T cells seem to
be activated in vivo.
In the case ofMRL/lpr- +/+ chimeras, transplantation
of fetal liver cells or T cell-depleted BM does not affect the
associated GVH-like disease (14), suggesting that mature T
cells, which express TCR-CD3 complex at high density and
are able to respond to antigen stimulation, are not indispens-
able to cause lpr GVH syndrome. There are two possibilities:
(a) wasting syndrome is mediated by non-T populations origi-
nated from lpr BM cells; and (b) T cell precursors in lpr BM
colonize and differentiate in the host thymus to produce
harmful mature T cells. We prefer the latter, considering our
data that lpr BM cells transplanted into nude mice did not
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Figure 4.
￿
IL2-R expression on various T cell
subsets (e-v). CD8-depleted thymocytes (a-n) were
set gate on Va6h,gh (e-g), V08high (h-k), and
V03high (i-n). Whole thymocytes are set gate on
CD3high (o-r). LN cells are set gate on Thy-1.2+
(s-v). Samples were obtained from MRL/+ -+
AKR (a, h, 1, o, and s), MRL/lpr -+ AKR (b,
e, i, m, p, and t), C57BL/6 -" AKR (c, f, j, n,
q, and u), and MRL/lpr -+ C3H chimera (d, g,
k, r, and v). C138-depleted samples (a-n) contained
<2% CD8' cells. Most (85-90%) of CD3high
thymocytes were CD4 or CD8 single positive, and
the remaining cells were mainly CD4*CD8'
cells. Data represent one of the five mice tested.
All the other four showed similar staining patterns
in each panel.
cause wasting or lymphoid aplasia (data not shown). Fur-
ther, the results presented here suggest an insufficient nega-
tive selection event in the lpr - AKR chimeras.
A direct approach to analyze the cellular basis of T cell
tolerance came from the observation that certain TCR V(3
domains are strongly correlated with reactivity to particular
antigens (31) . Such a direct link has been found between the
reactivity to the product of Mls' allele and TCR V06/
V08.1 (19, 28) expressed on T cells. In addition, all TCRs
using V03 have been shown to bind to the product of
Mls-2a (21, 32, 33). Mice expressing Mls' or Mlsc are found
to eliminate V06/Va8 .1- or V03-bearing T cells from their
mature T cell pool, respectively (19, 28, 31). A bulk of evi-
dence suggests that Mls tolerance can be transferred by he-
matopoietic cells. V06+ cells are deleted in both Mls, ->
Mlsb and Mlsb -> Mls' radiation chimeras (26, 27, 34).
Therefore, deletion of V06+ cells require the presence of
Mls' either on BM-derived cells or on irradiated recipient
cells. It has also been shown that Mls' and I-E requirements
can be genetically complemented in radiation BM chimeras,
i.e., V06/Va8.1 cells are deleted in situations where dele-
tion does not occur in either donor or host genotype alone.
For instance, V06/VO8.1 cells are deleted in a (Mlsb, I-E+)Table 2.
￿
Vigorous Anti-CD3 Response by LN Cellsfrom MRL/lpr-'AKR Chimeras
--> (Mlsa, I-E - ) chimera (35) . On the other hand, when
"nonpermissive" I-E or I-E- strain was used as a donor,
depletion of the V06/VO8.1 cells is incomplete (21, 34, 35).
Thereby, I-E expression on donor cells is both necessary and
sufficient to induce clonal deletion of V06+ cells in chi-
meras, irrespective of Mlsa source. In addition, recent im-
munohistological experiments revealed that most of medul-
lary Ia+ cells are of donor origin in the early stage of BM
chimeras (36). Collectively, it is highly likely that donor
BM-derived APC in the host thymus are responsible for in-
ducing clonal deletion.
A mechanism of deletion escape in MRL/lpr - AKR
chimeras should be discussed. As mentioned in Results, two
possibilities were postulated: (a) T cell precursors that ex-
press 1pr gene products neglect deletion signals from APC;
and (b) APC derived from 1pr inocula cannot induce sufficient
clonal deletion. Results from mixed chimeras suggested that
normal Mlsa APC have an ability to induce clonal deletion
to lpr-derived T cells, negating the first idea. Recent studies
reported that clonal deletion of potential self-reactive cells
does occur in untreated 1pr mice (37, 38) . Kotzin et al. (38)
have shown that T cells in AKR-Ipr/lpr mice have under-
gone a clonal elimination of V08.1+ cells. The disparity be-
tween their findings of clonal deletion on untreated 1pr mice
and our data on 1pr -> AKR chimeras may be explained as
follows. AKR mice homozygous for the 1pr gene contain cells
coexpressing products encoded by Mlsa and MHC class It
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The values represent the arithmetric mean (± SEM) of triplicate samples from one of two experiments. Thy-1.1+ cells are depleted, as described
in Materials and Methods to contain <1% Thy-1.1 " cells.',t,s Percentages of Thy-1.2+ cells were 60.8,' 63.5,1 55.7,5 81.5 (Thy-1.1),11 83.2,1
82.4,"' and 87.1.4 CD4/CD8 ratios were 3.4,' 3.9,t 2.7,S 1 .9,11 1.7,11.7,** and 1 .5,tt respectively. MRL/Ipr (11 wk) contained >40% Thy-1.2+
CD4-CD8 - cells,
genes that induce clonal deletion of Mlsa-reactive T cells in
the 1pr thymus without presenting transferable Mlsa in as-
sociation with self-MHC molecules. On the other hand, as
described above, in Mlsb - Mlsa chimeras, host-derived Mlsa
molecules have to be transferred to donor APC to induce clonal
deletion of V06/VQ8.1+ cells. It is likely that APC derived
from 1pr BM may have a deficit in presenting exogenous
Mlsa antigen in association with self-MHC molecules. Al-
though there are several lines of evidence for abnormality in
APC in 1pr mice (39-41), to our knowledge, our data appear
to show the first evidence that APC derived from 1pr BM
are deficient in tolerance-related antigen presenting ability.
Schneider et al. (42) demonstrated that CD4+ V06+ cells
are present during the early postnatal period in the thymus
of Mlsa mice. If self-reactive T cells develop preferentially in
the early stage of T cell ontogeny, thymectomy at early life
may bring a relative increase of forbidden self-reactive cells.
As for neonatally thymectomized mice, there are reports of
appearance ofpotentially self-reactive T cells that were deleted
in the adult thymus (43, and our observations) and develop-
ment of organ-specific autoimmune disease (44, 45). As shown
in Table 1, V(36 expression in MRL/lpr - AKR and C3H/lpr
-" AKR CD4+ T cells seems to be decreased with time
after BM transplantation. There remains a possibility that
clonal deletion is more "delayed" in these chimeras, as in a
neonate, than in their controls.
To elucidate whether failure of V(36 deletion is unique or
None
Proliferation with
0.025 (hg/ml)
cpm
anti-CD3
0.2 (wg/ml) 1,6 (jag/ml)
C3H- AKR" 399 5,489 6,863 9,204
(87) (255) (77) (1,343)
MRL/ +-AKRt 896 4,821 7,427 17,867
(285) (1,081) (1,986) (3;439)
MRL/1pr-AKRS 5,717 32,804 82,023 115,239
(1,508) (1,090) (5,106) (2,603)
AKR11 1,100 5,810 16,553 30,568
(450) (308) (1,987) (2,863)
MRL/ + 487 ND 8,399 16,709
(150) (1,154) (2,195)
MRL/lpr (7 wk)"' 437 ND 3,307 6,314
(323) (1,986) (1,814)
MRL/Ipr (11 wk)tt 556 ND 1,554 2,154
(443) (681) (1,081)one ofgeneralized failure to delete self-reactive cells, we per-
formed additional experiments of MRL --> C3H(Mls-2')
chimeric combination. However, there was no significant
difference between MRL/Ipr - OH and MRL/+ - OH
in degree of clonal deletion of Va3+ cells. Several explana-
tions for disparity between MRL - AKR and MRL - OH
chimeras are presumed as: (a) Ipr-derived T cells are relatively
susceptible to Mls°-deleting allele; (b) lpr-derived APC can
present Mlsc products, but not Mls'; and (c) thymic APC
of OH are comparatively radioresistant and there are enough
to delete Ipr-derived V03+ cells. Whatever the reason is,
high susceptibility of V03+ cells MRL/lpr-> OH may ac-
count for our observation that Ipr-associated wasting and de-
crease of peripheral lymphoid cellularity was less serious in
the OH host than in the AKR host .
In spite of occurrence of clonal deletion of V06+ cells,
progressive lymphoid atrophy was also observed in (MRL/Ipr
+ AKR) -> AKR mixed chimeras, as previously reported
by Perkins et al. (46), indicating that a mere defect in clonal
deletion is not sufficient to explain the pathology of Ipr -"
non-Ipr chimeras. High incidence of IIr2R+ cells in mature
T cells of MRL/lpr - AKR chimeras is another point to
be discussed. Particularly in the "forbidden" V06+ thymo-
cytes in 1pr -" AKR chimeras, nearly 40% was IIr2R+ . Al-
though the V#3+ subset, which is not a "forbidden" clone,
seen in Ipr -> AKR chimeras also contained more IIr2R+
cells than MRL/+ -" AKR chimeras, the percentage was
lower than the V06+ subset of the identical individuals.
Since we use 7D4 as anti-IL2R antibody, which detects only
the a chain of the IIr2R, it may not be concluded that this
reflects functional IIr2R on T cells. However, Butler et al.
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(47) reported that the kinetics of expression ofthe IL2R(7D4)
closely corelates with antigen sensitization and proliferative
response in vivo, and that tolerance induction or treatment
with immunosuppressive drugs reduce IIr2R+ cells at the
population level. Therefore, it could be reasonable to use
IL2R(7D4) expression as an index of cell activation in vivo.
Although, at present, we cannot define what the lpr-derived
T cells recognize, it is likely that mature T cells not under-
going clonal deletion recognize host antigen and proliferate
in MRL/Ipr - AKR chimeras. Recently, Ramsdell et al.
(48) have shown that some combinations of BM chimeras
like SJL(Mls-1b,H-2s) -+ (B10.S x AKR)F1(Mls-1'.b,H-2ti.s)
do not cause clonal deletion of Vf6+ cells. In spite of con-
taining "forbidden" Vf6+ cells, mature T cells in these
chimeras were tolerant to host antigens as a consequence of
probable clonal anergy. Turning to the case of MRL/1pr ->
AKR chimeras, from high anti-CD3 response, it maybe con-
sidered that clonal anergy or suppressor mechanism are also
disordered, as well as the clonal deletion mechanism. Mature
T cells generated in MRL/Ipr - AKR chimeras were spon-
taneously proliferating (Table 2) but decreasing in number.
Their features are quite different from accumulated Ipr LN
cells, which exhibit a profound defect in proliferation, IIr2
production, IL2R expression (49-51), and anti-CD3 mAb
responsiveness (52). Both the non-Ipr thymic environment
(including Ipr-derived APC) and an intrinsic defect of lpr T
cells may increase such activated T cells, which may contribute
to subsequent manifestation of GVHD-like syndrome. Al-
though the main target of the activated T cells remains to
be identified, the lpr - non-1pr BM chimeras seem to be an
interesting model for understanding of self-tolerance.
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